Data: Leading Medical and Biotechnology rose more than 240% intraday, after announcing plans to acquire all equity of Conflux

Hong Kong-listed Leading Pharmaceutical & Biotechnology (00399) saw a surge in trading volume and price in early trading today, with an intraday increase of nearly 240.00%. The stock price reached a high of HK$0.7, before falling back to around HK$0.34. The company had previously announced plans to acquire all the equity of the blockchain project Conflux to expand its presence in the blockchain field. Two founding members of Conflux currently serve as its executive directors. [ChainCatcher]